ArticleBMC public health2025
PrEP attitudes, willingness, and preferences among men incarcerated in jail in Massachusetts.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeople who inject drugs (PWID) are both disproportionately incarcerated and affected by HIV infection. Systemic inequities perpetuate the cyclic nature of injection drug use (IDU) and incarceration, and both IDU and incarceration are linked to higher rates of HIV infection. Pre-exposure prophylaxis (PrEP) is highly effective in HIV prevention and is currently available as a daily oral pill. Longer-acting PrEP options, such as injectables and implants, are also in development to improve accessibility and adherence. Despite these advancements, PrEP uptake remains low among PWID and individuals recently released from jail, and there is limited literature exploring the preferences for PrEP uptake within this population.
methodsWe conducted qualitative interviews using a semi-structured interview guide with 20 male participants (19 incarcerated in a Massachusetts jail and 1 recently released) to assess perceived HIV risk, knowledge of PrEP, barriers to PrEP uptake, and preferences for PrEP modality and frequency. The data were analyzed using a directed content analysis approach.
resultsMost participants were aware of their HIV risk but were largely unaware of PrEP and had never been educated about PrEP by a healthcare provider. Participants cited a lack of access to healthcare, stigma around HIV infection, and feasibility as barriers to uptake. While participants expressed interest in longer-acting PrEP, most preferred the oral pill due to distrust of the safety and efficacy of injectables and implants, countering the assumption that modality changes alone can improve low PrEP uptake.
conclusionsOur findings underscore the urgent need for targeted education and interventions to improve HIV prevention in vulnerable populations impacted by incarceration. While long-acting injectables have been touted to help address barriers to accessing healthcare among this population, skepticism about the efficacy of long-acting injectables among this population may prevent these efforts. It is important to further research the willingness to uptake PrEP and modality preferences among this population to meet their needs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.